Skip to main content

MoneyWorks4Me

Cipla informs about press release

25 Jul 2019 Evaluate

Cipla has informed that it has enclosed press release titled 'Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI (IV Plazomicin).'.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..